Taking a page from Pfizer’s manufacturing playbook—and following in the recent footsteps of Eli Lilly and Merck & Co.—generics juggernaut Viatris is the latest drugmaker angling to boost production autonomy overseas.
Pfizer partners with Medochemie to make drugs in Vietnam